Entry - #212050 - IMMUNODEFICIENCY 103, SUSCEPTIBILITY TO FUNGAL INFECTIONS; IMD103 - OMIM
# 212050

IMMUNODEFICIENCY 103, SUSCEPTIBILITY TO FUNGAL INFECTIONS; IMD103


Alternative titles; symbols

CANDIDIASIS, FAMILIAL, 2; CANDF2
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE
CARD9 IMMUNODEFICIENCY


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
9q34.3 Immunodeficiency 103, susceptibility to fungal infection 212050 AR 3 CARD9 607212
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
HEAD & NECK
Head
- Tinea capitis, severe or recurrent
Mouth
- Candidiasis, chronic
ABDOMEN
Gastrointestinal
- Dermatophytic invasion of gastrointestinal tract (in some patients)
GENITOURINARY
Internal Genitalia (Female)
- Vaginal candidiasis, chronic
SKELETAL
Feet
- Dermatophytic invasion of bone (in some patients)
SKIN, NAILS, & HAIR
Skin
- Tinea capitis, severe or recurrent
- Dermatophytosis, chronic
- Deep dermatophytosis (in some patients)
Skin Histology
- Granulomatous dermatitis
- Macrophage infiltration of dermis
- Epithelioid cell infiltration of dermis
- Multinucleated giant cells in dermis
- Hyphae and pseudohyphae within granulomas
- Hyphae and pseudohyphae in cytoplasm of multinucleated giant cells
Electron Microscopy
- Abnormally bulging phagolysosomes in neutrophils after uptake of Candida albicans
Nails
- Onychomycosis
NEUROLOGIC
Central Nervous System
- Candidal meningitis (in some patients)
HEMATOLOGY
- Iron deficiency (in some patients)
IMMUNOLOGY
- Immunodeficiency
- Dermatophytic lymphadenitis (in some patients)
MOLECULAR BASIS
- Caused by mutation in the caspase recruitment domain containing 9 (CARD9, 607212.0001)
Familial candidiasis - PS114580 - 8 Entries
Immunodeficiency (select examples) - PS300755 - 143 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.33 Immunodeficiency 38 AR 3 616126 ISG15 147571
1p36.33 ?Immunodeficiency 16 AR 3 615593 TNFRSF4 600315
1p36.23 Immunodeficiency 109 with lymphoproliferation AR 3 620282 TNFRSF9 602250
1p36.22 Immunodeficiency 14A, autosomal dominant AD 3 615513 PIK3CD 602839
1p36.22 Immunodeficiency 14B, autosomal recessive AR 3 619281 PIK3CD 602839
1p35.2 Immunodeficiency 22 AR 3 615758 LCK 153390
1p34.2 Immunodeficiency 24 AR 3 615897 CTPS1 123860
1p22.3 ?Immunodeficiency 37 AR 3 616098 BCL10 603517
1q21.3 Immunodeficiency 42 AR 3 616622 RORC 602943
1q23.3 Immunodeficiency 20 AR 3 615707 FCGR3A 146740
1q24.2 ?Immunodeficiency 25 AR 3 610163 CD247 186780
1q25.3 Immunodeficiency 133 with autoimmunity and autoinflammation AR 3 620565 ARPC5 604227
1q25.3 Immunodeficiency 70 AD 3 618969 IVNS1ABP 609209
1q31.3-q32.1 Immunodeficiency 105, severe combined AR 3 619924 PTPRC 151460
2p16.1 Immunodeficiency 92 AR 3 619652 REL 164910
2p11.2 Immunodeficiency 116 AR 3 608957 CD8A 186910
2q11.2 Immunodeficiency 48 AR 3 269840 ZAP70 176947
2q24.2 Immunodeficiency 95 AR 3 619773 IFIH1 606951
2q32.2 Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant AD 3 614162 STAT1 600555
2q32.2 Immunodeficiency 31A, mycobacteriosis, autosomal dominant AD 3 614892 STAT1 600555
2q32.2 Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive AR 3 613796 STAT1 600555
2q33.2 ?Immunodeficiency 123 with HPV-related verrucosis AR 3 620901 CD28 186760
2q35 Immunodeficiency 124, severe combined AR 3 611291 NHEJ1 611290
3p22.2 Immunodeficiency 68 AR 3 612260 MYD88 602170
3q21.3 Immunodeficiency 21 AD 3 614172 GATA2 137295
3q21.3 ?Immunodeficiency 128 AR 3 620983 COPG1 615525
3q29 Immunodeficiency 46 AR 3 616740 TFRC 190010
4p14 Immunodeficiency 129 AR 3 618307 RHOH 602037
4q24 Immunodeficiency 75 AR 3 619126 TET2 612839
4q35.1 {Immunodeficiency 83, susceptibility to viral infections} AD, AR 3 613002 TLR3 603029
5p15.2 {Immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection} AD 3 619986 OTULIN 615712
5p13.2 Immunodeficiency 104, severe combined AR 3 608971 IL7R 146661
5q11.2 ?Immunodeficiency 94 with autoinflammation and dysmorphic facies AD 3 619750 IL6ST 600694
5q13.1 Immunodeficiency 36 AD 3 616005 PIK3R1 171833
5q31.1 Immunodeficiency 93 and hypertrophic cardiomyopathy AR 3 619705 FNIP1 610594
5q31.1 Immunodeficiency 117, mycobacteriosis, autosomal recessive AR 3 620668 IRF1 147575
5q33.3 Immunodeficiency 29, mycobacteriosis AR 3 614890 IL12B 161561
5q35.1 Immunodeficiency 40 AR 3 616433 DOCK2 603122
5q35.1 Immunodeficiency 81 AR 3 619374 LCP2 601603
6p25.3 Immunodeficiency 131 AD, AR 3 621097 IRF4 601900
6p25.2 Immunodeficiency 57 with autoinflammation AR 3 618108 RIPK1 603453
6p21.33 ?Immunodeficiency 127 AR 3 620977 TNF 191160
6p21.31 Immunodeficiency 87 and autoimmunity AR 3 619573 DEF6 610094
6p21.1 Immunodeficiency 126 AR 3 620931 PTCRA 606817
6q14.1 Immunodeficiency 23 AR 3 615816 PGM3 172100
6q15 Immunodeficiency 60 and autoimmunity AD 3 618394 BACH2 605394
6q23.3 Immunodeficiency 27B, mycobacteriosis, AD AD 3 615978 IFNGR1 107470
6q23.3 Immunodeficiency 27A, mycobacteriosis, AR AR 3 209950 IFNGR1 107470
7p22.2 Immunodeficiency 11A AR 3 615206 CARD11 607210
7p22.2 Immunodeficiency 11B with atopic dermatitis AD 3 617638 CARD11 607210
7q22.1 Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia AR 3 617718 ARPC1B 604223
7q22.3 Immunodeficiency 97 with autoinflammation AR 3 619802 PIK3CG 601232
8p11.21 Immunodeficiency 15A AD 3 618204 IKBKB 603258
8p11.21 Immunodeficiency 15B AR 3 615592 IKBKB 603258
8q11.21 Immunodeficiency 26, with or without neurologic abnormalities AR 3 615966 PRKDC 600899
8q11.21 Immunodeficiency 54 AR 3 609981 MCM4 602638
8q21.13 Immunodeficiency 130 with HPV-related verrucosis AR 3 618309 IL7 146660
9q22.2 Immunodeficiency 82 with systemic inflammation AD 3 619381 SYK 600085
9q34.3 Immunodeficiency 103, susceptibility to fungal infection AR 3 212050 CARD9 607212
10p15.1 Immunodeficiency 41 with lymphoproliferation and autoimmunity AR 3 606367 IL2RA 147730
10p13 Immunodeficiency 80 with or without cardiomyopathy AR 3 619313 MCM10 609357
11p15.5 ?Immunodeficiency 39 AR 3 616345 IRF7 605047
11p15.4 Immunodeficiency 10 AR 3 612783 STIM1 605921
11q12.1 Immunodeficiency 77 AD 3 619223 MPEG1 610390
11q13.3 Immunodeficiency 90 with encephalopathy, functional hyposplenia, and hepatic dysfunction AR 3 613759 FADD 602457
11q13.4 Immunodeficiency 122 AR 3 620869 POLD3 611415
11q23.3 Immunodeficiency 18, SCID variant AR 3 615615 CD3E 186830
11q23.3 Immunodeficiency 18 AR 3 615615 CD3E 186830
11q23.3 Immunodeficiency 19, severe combined AR 3 615617 CD3D 186790
11q23.3 Immunodeficiency 17, CD3 gamma deficient AR 3 615607 CD3G 186740
11q23.3 ?Immunodeficiency 59 and hypoglycemia AR 3 233600 HYOU1 601746
12p13.31 Immunodeficiency 79 AR 3 619238 CD4 186940
12q12 Immunodeficiency 67 AR 3 607676 IRAK4 606883
12q13.13-q13.2 Immunodeficiency 72 with autoinflammation AR 3 618982 NCKAP1L 141180
12q13.3 Immunodeficiency 44 AR 3 616636 STAT2 600556
12q15 ?Immunodeficiency 69, mycobacteriosis AR 3 618963 IFNG 147570
12q24.13 Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinemia AD 3 618042 OAS1 164350
12q24.31 Immunodeficiency 9 AR 3 612782 ORAI1 610277
13q33.1 Immunodeficiency 78 with autoimmunity and developmental delay AR 3 619220 TPP2 190470
14q11.2 Immunodeficiency 7, TCR-alpha/beta deficient AR 3 615387 TRAC 186880
14q11.2 ?Immunodeficiency 108 with autoinflammation AR 3 260570 CEBPE 600749
14q12 Immunodeficiency 115 with autoinflammation AR 3 620632 RNF31 612487
14q12 Immunodeficiency 65, susceptibility to viral infections AR 3 618648 IRF9 147574
14q32.2 Immunodeficiency 49, severe combined AD 3 617237 BCL11B 606558
14q32.32 Immunodeficiency 132B AD 3 621096 TRAF3 601896
14q32.32 Immunodeficiency 132A AD 3 614849 TRAF3 601896
15q14 Immunodeficiency 64 AR 3 618534 RASGRP1 603962
15q21.1 Immunodeficiency 43 AR 3 241600 B2M 109700
15q21.2 Immunodeficiency 86, mycobacteriosis AR 3 619549 SPPL2A 608238
16p12.1 Immunodeficiency 56 AR 3 615207 IL21R 605383
16p11.2 Immunodeficiency 52 AR 3 617514 LAT 602354
16p11.2 Immunodeficiency 8 AR 3 615401 CORO1A 605000
16q22.1 Immunodeficiency 58 AR 3 618131 CARMIL2 610859
16q22.1 Immunodeficiency 121 with autoinflammation AD 3 620807 PSMB10 176847
16q24.1 Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive AR 3 226990 IRF8 601565
16q24.1 Immunodeficiency 32A, mycobacteriosis, autosomal dominant AD 3 614893 IRF8 601565
17q11.2 ?Immunodeficiency 13 AD 3 615518 UNC119 604011
17q12-q21.1 ?Immunodeficiency 84 AD 3 619437 IKZF3 606221
17q21.31 Immunodeficiency 112 AR 3 620449 MAP3K14 604655
17q21.32 ?Immunodeficiency 88 AR 3 619630 TBX21 604895
18q21.32 Immunodeficiency 12 AR 3 615468 MALT1 604860
19p13.3 Hatipoglu immunodeficiency syndrome AR 3 620331 DPP9 608258
19p13.2 Immunodeficiency 35 AR 3 611521 TYK2 176941
19p13.11 Immunodeficiency 76 AR 3 619164 FCHO1 613437
19p13.11 Immunodeficiency 30 AR 3 614891 IL12RB1 601604
19q13.2 ?Immunodeficiency 62 AR 3 618459 ARHGEF1 601855
19q13.32 ?Immunodeficiency 53 AR 3 617585 RELB 604758
19q13.33 Immunodeficiency 96 AR 3 619774 LIG1 126391
19q13.33 ?Immunodeficiency 125 AR 3 620926 FLT3LG 600007
19q13.33 Immunodeficiency 120 AR 3 620836 POLD1 174761
20p11.23 ?Immunodeficiency 101 (varicella zoster virus-specific) AD 3 619872 POLR3F 617455
20p11.21 Immunodeficiency 55 AR 3 617827 GINS1 610608
20q11.23 ?Immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias AR 3 619846 CTNNBL1 611537
20q13.12 T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations AR 3 614868 STK4 604965
20q13.13 Immunodeficiency 91 and hyperinflammation AR 3 619644 ZNFX1 618931
21q22.11 Immunodeficiency 45 AR 3 616669 IFNAR2 602376
21q22.11 Immunodeficiency 106, susceptibility to viral infections AR 3 619935 IFNAR1 107450
21q22.11 Immunodeficiency 28, mycobacteriosis AR 3 614889 IFNGR2 147569
21q22.3 ?Immunodeficiency 119 AR 3 620825 ICOSLG 605717
21q22.3 Immunodeficiency 114, folate-responsive AR 3 620603 SLC19A1 600424
22q11.1 Immunodeficiency 51 AR 3 613953 IL17RA 605461
22q12.3 ?Immunodeficiency 85 and autoimmunity AD 3 619510 TOM1 604700
22q12.3 Immunodeficiency 63 with lymphoproliferation and autoimmunity AR 3 618495 IL2RB 146710
22q13.1 Immunodeficiency 73A with defective neutrophil chemotaxix and leukocytosis AD 3 608203 RAC2 602049
22q13.1 ?Immunodeficiency 73C with defective neutrophil chemotaxis and hypogammaglobulinemia AR 3 618987 RAC2 602049
22q13.1 Immunodeficiency 73B with defective neutrophil chemotaxis and lymphopenia AD 3 618986 RAC2 602049
22q13.1 ?Immunodeficiency 89 and autoimmunity AR 3 619632 CARD10 607209
22q13.1-q13.2 ?Immunodeficiency 66 AR 3 618847 MKL1 606078
Xp22.2 Immunodeficiency 74, COVID19-related, X-linked XLR 3 301051 TLR7 300365
Xp22.2 Immunodeficiency 98 with autoinflammation, X-linked SMo, XL 3 301078 TLR8 300366
Xp22.12 ?Immunodeficiency 61 XLR 3 300310 SH3KBP1 300374
Xp21.1-p11.4 Immunodeficiency 34, mycobacteriosis, X-linked XLR 3 300645 CYBB 300481
Xp11.23 Wiskott-Aldrich syndrome XLR 3 301000 WAS 300392
Xq12 Immunodeficiency 50 XLR 3 300988 MSN 309845
Xq13.1 Severe combined immunodeficiency, X-linked XLR 3 300400 IL2RG 308380
Xq13.1 Combined immunodeficiency, X-linked, moderate XLR 3 312863 IL2RG 308380
Xq22.1 Agammaglobulinemia, X-linked 1 XLR 3 300755 BTK 300300
Xq24 Immunodeficiency 118, mycobacteriosis XLR 3 301115 MCTS1 300587
Xq25 Lymphoproliferative syndrome, X-linked, 1 XLR 3 308240 SH2D1A 300490
Xq26.1 Immunodeficiency 102 XLR 3 301082 SASH3 300441
Xq26.3 Immunodeficiency, X-linked, with hyper-IgM XLR 3 308230 TNFSF5 300386
Xq28 Immunodeficiency 47 XLR 3 300972 ATP6AP1 300197
Xq28 Immunodeficiency 33 XLR 3 300636 IKBKG 300248

TEXT

A number sign (#) is used with this entry because of evidence that immunodeficiency-103 (IMD103) is caused by homozygous or compound heterozygous mutation in the CARD9 gene (607212) on chromosome 9q34.


Clinical Features

Wells et al. (1972) investigated 46 patients with chronic oral candidiasis. Within the series they recognized a 'new' syndrome, present in 22 cases. The nails and skin were sometimes affected. Eighteen cases in 8 kindreds were studied. Parental consanguinity was demonstrated in 4 of these. A group of severely affected patients probably had a distinct disorder which may be nongenetic, although new autosomal dominant mutation could not be excluded. A late-onset group of cases of oral candidiasis appeared to be nongenetic. Of 14 fully investigated patients with familial chronic mucocutaneous candidiasis, 10 were found to have iron deficiency. Higgs and Wells (1972) discussed a familial form and suggested a relationship to transferrin type (which remains to be proved).

A clinically and possibly genetically distinct, seemingly autosomal recessive form of chronic mucocutaneous candidiasis was reported in families of French Canadian descent, originating from eastern Quebec (Germain et al., 1994). The disorder was of mild nature with adult onset, but complicated by fatal Candida meningitis. A total of 5 patients were reviewed. Germain et al. (1994) suggested that the disorder represents a variant of familial adult-onset chronic mucocutaneous candidiasis in which there is a striking predisposition to deep infection. Immunologic investigation showed a specific cellular deficit toward Candida albicans. One patient who died of meningitis was a 28-year-old woman who had suffered from recurrent episodes of mild oral thrush since age 16 years. She had no skin or nail involvement.

Boudghene-Stambouli and Merad-Boudia (1998) described a 29-year-old Algerian man, born of first-cousin parents, who had a 2-year history of progressive dermatophytic disease consisting of exuberant hyperkeratosis and cutaneous horns. Examination revealed erythematous flat plaques with distinct borders on the trunk, limbs, and neck, with verrucous midface lesions and other eczema-like lesions on the face, as well as papulonodular lesions around the left nipple. The lesions were intensely pruritic, and chronic scratching had caused lichenification. On the anterior plantar surface of each foot, there was a wide-based, dark-brown hard horn that made walking difficult. In addition, the patient had pachyonychia of all nails, some of which exhibited onychogryphosis. Histologic examination of affected skin showed acanthosis and papillomatosis of the epidermis, with marked hyperkeratosis. The stratum corneum was invaded by hyphae that penetrated into the sweat glands and hair follicles, and abscesses and small granulomas containing hyphae were seen in the superficial dermis. No other family members were affected. Boudghene-Stambouli and Merad-Boudia (1998) suggested that this phenotype with giant cutaneous horns represented a new variant of dermatophytic disease.

Glocker et al. (2009) studied a large consanguineous Iranian family segregating autosomal recessive chronic mucocutaneous candidiasis. Recurrent fungal infections were diagnosed clinically in 8 family members, 3 of whom died in early adolescence, 2 with proven and 1 with presumed invasive Candida infection of the brain. None of the 8 infected patients had unusual bacterial or viral infections, suggesting that host defenses against those pathogens was normal. In the 3 patients for whom laboratory studies were available, complete blood counts were within the normal range, as were total counts of CD3+, CD4+, and CD8+ T cells; memory, follicular helper, effector, and regulatory T cells; B cells; and natural killer cells. Basal levels of serum immunoglobulin were also normal. In 1 patient, a delayed-type hypersensitivity skin test was negative for tuberculin but positive for Candida. Compared to healthy family members and controls, affected family members had significantly lower proportions of Th17 cells, helper T cells producing interleukin-17 (603149) that are important for antifungal immunity.

Drewniak et al. (2013) studied a 13-year-old Asian girl who was adopted as an infant and at 7 years of age developed fever, headaches, behavioral changes, and seizures. She was diagnosed with Candida dubliniensis meningoencephalitis, but did not have any obvious underlying risk factors for fungal meningitis. MRI showed a deep infarction of the left striatum, meningeal enhancement, and mild ventricular dilation. After 6 months of antimycotic treatment, its discontinuation resulted in a clinical relapse, and cerebrospinal fluid (CSF) cultures revealed C. dubliniensis. Clinical signs and CSF eosinophilic pleocytosis resolved within several weeks of restarting combined antifungal therapy. Western blot analysis of patient neutrophils showed apparent absence of CARD9 protein, and this was confirmed with anti-CARD9 antibodies. Activated patient T-cell cultures showed clear induction of various cytokines but reduced levels of Th17-derived IL17 (see 603149), consistent with the findings of Glocker et al. (2009).

Lanternier et al. (2013) described 17 patients from 8 unrelated families of Moroccan, Tunisian, and Algerian ancestry, including the Algerian family originally described by Boudghene-Stambouli and Merad-Boudia (1998), who had deep dermatophytosis and no known immunodeficiency. In all patients, symptoms first appeared in childhood or early adulthood. Four patients had adenitis caused by dermatophyte infection, and 13 had documented cutaneous deep dermatophytosis. Skin lesions included extensive erythematosquamous lesions and nodular subcutaneous or ulcerative fistulized infiltrations. Fifteen patients had severe onychomycosis, and 2 patients had contiguous locoregional extension to the bone or digestive tract; manifestations of the disease in other extradermatologic locations included lymphadenopathy in 10 patients and probable brain involvement in 1. Four patients with clinically active deep dermatophytosis died at the ages of 28, 29, 37, and 39 years. None of the 17 patients had any detectable T-cell immunodeficiency known to confer a predisposition to severe dermatophyte infection. Skin histology showed multifocal-to-coalescing granulomatous dermatitis that extended throughout the dermis and was characterized by infiltrates of activated macrophages and epithelioid cells, associated with lymphocytes, plasma cells, neutrophils, and eosinophils. Pseudohyphae and irregularly branched hyaline septate hyphae could be seen within granulomas and sometimes even in the cytoplasm of multinucleated giant cells. Lymph node histology revealed granulomas containing hyphae and necrosis in 4 patients.

Wang et al. (2014) reported 4 unrelated patients with subcutaneous phaeohyphomycosis caused by P. verrucosa and Th17 cell deficiencies.

Wang et al. (2018) reported 3 patients, aged 18, 38 and 53 years, with phaeohyphomycosis caused by rare dermatiaceous fungi. Histopathologic analysis of skin from each patient demonstrated infectious granulomas with irregularly branched brown hyphae and lack of neutrophil infiltration.

Paccoud et al. (2022) reported a Moroccan patient who developed an ulcer on her ankle at 22 years of age when she was pregnant. A biopsy of the lesion showed spherical hyphae and she was treated with surgical excision and amphotericin B. She developed a hard-palate necrosis at age 25 during a subsequent pregnancy. The lesion did not heal despite treatment with amphotericin, and at age 28, she had lesions of the dosum nasi and hard palate with destruction of the nasal septum. The infection was shown to be due to Alternaria infectoria.


Pathogenesis

In peripheral blood mononuclear cells (PBMCs) from a 13-year-old Asian girl with chronic Candida dubliniensis meningoencephalitis and CARD9 deficiency, Drewniak et al. (2013) observed a virtual absence of Candida-induced monocytic IL6 (147620) and IL1B (147720) release. The response to bacteria and various TLR (see 603030) ligands was only partly affected or not at all, and cells transduced with CARD9 showed recovery of monocytic cytokines. Patient neutrophils demonstrated a normal capacity to generate reactive oxygen species and normal recognition and signaling for immediate responses. Neutrophil-killing capacity of CARD9-deficient cells was significantly impaired with unopsonized C. albicans conidia, but was normal with serum-opsonized conidia, and with opsonized S. aureus or E. coli. Ultrastructural analysis showed abnormal bulging phagolysosome formation upon uptake of C. albicans in patient neutrophils compared to controls. Drewniak et al. (2013) concluded that CARD9 deficiency results in a selective defect in host defense against invasive fungal infection, due to impaired phagocyte killing.


Mapping

Glocker et al. (2009) performed homozygosity mapping in a large consanguineous Iranian family with chronic mucocutaneous candidiasis and identified a region of perfect segregation on chromosome 9; genotyping 4 microsatellite markers yielded a peak multipoint lod score of 3.6 at an interval defined by the markers D9S2157 and D9S1838. Forty-one genes were located in a perfectly segregating 1.3-Mb subinterval suggested by SNP data.


Inheritance

The transmission pattern of IMD103 in the family reported by Glocker et al. (2009) was consistent with autosomal recessive inheritance.


Molecular Genetics

In a large consanguineous Iranian family segregating autosomal recessive chronic mucocutaneous candidiasis mapping to chromosome 9, Glocker et al. (2009) identified homozygosity for a nonsense mutation (Q295X; 607212.0001) in the CARD9 gene in all 4 affected individuals. Eighteen other unaffected family members were either heterozygous or did not carry the Q295X mutation, and the mutation was not found in 50 unrelated Iranian controls or in 180 unrelated Caucasian controls. Functional studies showed that Q295X is a loss-of-function mutation that impairs innate signaling from the antifungal pattern-recognition receptor dectin-1 (CLEC7A; 606264).

In a 13-year-old Asian girl with chronic Candida dubliniensis meningoencephalitis, in whom CARD9 appeared to be absent from neutrophils, Drewniak et al. (2013) identified compound heterozygosity for 2 missense mutations in the CARD9 gene, G72S (607212.0002) and R373P (607212.0003).

In affected individuals from 8 families of Algerian, Tunisian, and Moroccan ancestry with deep dermatophytosis, including the Algerian family previously studied by Boudghene-Stambouli and Merad-Boudia (1998), Lanternier et al. (2013) analyzed the candidate gene CARD9 and identified homozygosity for a nonsense mutation (Q289X; 607212.0004) in 7 of the families; patients from the eighth family were homozygous for a CARD9 missense mutation (R101C; 607212.0005). The mutations segregated fully with disease in each family and were not found in ethnically matched controls, in more than 1,000 exomes, or in the 1000 Genomes Project database.

Wang et al. (2014) identified biallelic mutations in the CARD9 gene in 4 unrelated Chinese patients with subcutaneous phaeohyphomycosis, including 1 (patient 1) with compound heterozygous mutations (607212.0006-607212.0007) and 3 (patients 2-4) with a homozygous mutation (607212.0008). Haplotype analysis in the homozygous patients demonstrated that the mutation likely arose from a shared founder. In patients 1, 2, and 3, expression of mature CARD9 protein was absent in peripheral mononuclear blood cells, and Th17 cells and the related cytokines IL17 and IL22 (605330) were decreased in blood/serum. Induced macrophages and immature dendritic cells from patients 1 and 3 secreted lower cytokines when exposed to P. verrucosa spores compared to controls. Wang et al. (2014) concluded that these results confirm the pivotal role of CARD9 in antifungal defense.

Wang et al. (2018) identified biallelic mutations in the CARD9 gene in 3 unrelated Chinese patients with IMD103, including compound heterozygous mutations (607212.0006, 607212.0008, 607212.0009) in 2 (patients 1 and 3) and a homozygous mutation (607212.0008) in 1 (patient 2). CARD9 protein expression was absent in polymorphonuclear cells from each patient. Studies in cells from patient 1 showed impaired proinflammatory chemokine (TNF-alpha, 191160; IL6, 147620; IL1B, 147720) and cytokine (CXCL1, 155730; CXCL2, 139110; CXCL8, 146930) production, deficient NF-kappa-B (see 164011) activation, and impaired Th22 and Th17 cells following fungal stimulation.


REFERENCES

  1. Boudghene-Stambouli, O., Merad-Boudia, A. Maladie dermatophytique: hyperkeratose exuberante avec cornes cutanees. Ann. Derm. Venereol. 125: 705-707, 1998. [PubMed: 9835960, related citations]

  2. Drewniak, A., Gazendam, R. P., Tool, A. T. J., van Houdt, M., Jansen, M. H., van Hamme, J. L., van Leeuwen, E. M. M., Roos, D., Scalais, E., de Beaufort, C., Janssen, H., van den Berg, T. K., Kuijpers, T. W. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121: 2385-2392, 2013. [PubMed: 23335372, related citations] [Full Text]

  3. Germain, M., Gourdeau, M., Hebert, J. Familial chronic mucocutaneous candidiasis complicated by deep Candida infection. Am. J. Med. Sci. 307: 282-283, 1994. [PubMed: 8160723, related citations] [Full Text]

  4. Glocker, E.-O., Hennigs, A., Nabavi, M., Schaffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., Jamal, S., Manguiat, A., Rezaei, N., Amirzargar, A. A., Plebani, A., Hannesschlager, N., Gross, O., Ruland, J., Grimbacher, B. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. New Eng. J. Med. 361: 1727-1735, 2009. [PubMed: 19864672, images, related citations] [Full Text]

  5. Higgs, J. M., Wells, R. S. Chronic muco-cutaneous candidiasis: associated abnormalities of iron metabolism. Brit. J. Derm. 86 (suppl. 8): 88-102, 1972.

  6. Lanternier, F., Pathan, S., Vincent, Q. B., Liu, L., Cypowyj, S., Prando, C., Migaud, M., Taibi, L., Ammar-Khodja, A., Boudghene Stambouli, O., Guellil, B., Jacobs, F., and 21 others. Deep dermatophytosis and inherited CARD9 deficiency. New Eng. J. Med. 369: 1704-1714, 2013. [PubMed: 24131138, images, related citations] [Full Text]

  7. Paccoud, O., Vignier, N., Boui, M., Migaud, M., Vironneau, P., Kania, R., Mechai, F., Brun, S., Alanio, A., Tauziede-Espariat, A., Adle-Biassette, H., Ouedraogo, E., Bustamante, J., Bouchaud, O., Casanova, J. L., Puel, A., Lanternier, F. Invasive rhinosinusitis caused by Alternaria infectoria in a patient with autosomal recessive CARD9 deficiency and a review of the literature. J Fungi (Basel) 8: 446, 2022. [PubMed: 35628702, images, related citations] [Full Text]

  8. Wang, X., Wang, W., Lin, Z., Wang, X., Li, T., Yu, J., Liu, W., Tong, Z., Xu, Y., Zhang, J., Guan, L., Dai, L., Yang, Y., Han, W., Li, R. CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies. (Letter) J. Allergy Clin. Immun. 133: 905-8.e3, 2014. [PubMed: 24231284, related citations] [Full Text]

  9. Wang, X., Zhang, R., Wu, W., Song, Y., Wan, Z., Han, W., Li, R. Impaired specific antifungal immunity in CARD9-deficient patients with phaeohyphomycosis. J. Invest. Derm. 138: 607-617, 2018. [PubMed: 29080677, related citations] [Full Text]

  10. Wells, R. S., Higgs, J. M., McDonald, A., Valdimarsson, H., Holt, P. J. L. Familial chronic muco-cutaneous candidiasis. J. Med. Genet. 9: 302-310, 1972. [PubMed: 4562433, related citations] [Full Text]


Hilary J. Vernon - updated : 10/05/2022
Hilary J. Vernon - updated : 07/27/2022
Marla J. F. O'Neill - updated : 8/14/2015
Marla J. F. O'Neill - updated : 11/20/2013
Marla J. F. O'Neill - updated : 10/30/2009
Creation Date:
Victor A. McKusick : 6/3/1986
carol : 04/02/2024
carol : 10/05/2022
carol : 07/28/2022
carol : 07/27/2022
carol : 06/17/2022
carol : 06/16/2022
carol : 08/17/2015
mcolton : 8/14/2015
carol : 8/26/2014
carol : 11/20/2013
mcolton : 11/15/2013
carol : 11/2/2009
terry : 10/30/2009
alopez : 3/18/2004
carol : 10/26/2001
carol : 5/24/1994
mimadm : 2/19/1994
supermim : 3/16/1992
supermim : 3/20/1990
ddp : 10/26/1989
marie : 3/25/1988

# 212050

IMMUNODEFICIENCY 103, SUSCEPTIBILITY TO FUNGAL INFECTIONS; IMD103


Alternative titles; symbols

CANDIDIASIS, FAMILIAL, 2; CANDF2
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE
CARD9 IMMUNODEFICIENCY


SNOMEDCT: 1186719000;   ORPHA: 457088;   DO: 2058;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
9q34.3 Immunodeficiency 103, susceptibility to fungal infection 212050 Autosomal recessive 3 CARD9 607212

TEXT

A number sign (#) is used with this entry because of evidence that immunodeficiency-103 (IMD103) is caused by homozygous or compound heterozygous mutation in the CARD9 gene (607212) on chromosome 9q34.


Clinical Features

Wells et al. (1972) investigated 46 patients with chronic oral candidiasis. Within the series they recognized a 'new' syndrome, present in 22 cases. The nails and skin were sometimes affected. Eighteen cases in 8 kindreds were studied. Parental consanguinity was demonstrated in 4 of these. A group of severely affected patients probably had a distinct disorder which may be nongenetic, although new autosomal dominant mutation could not be excluded. A late-onset group of cases of oral candidiasis appeared to be nongenetic. Of 14 fully investigated patients with familial chronic mucocutaneous candidiasis, 10 were found to have iron deficiency. Higgs and Wells (1972) discussed a familial form and suggested a relationship to transferrin type (which remains to be proved).

A clinically and possibly genetically distinct, seemingly autosomal recessive form of chronic mucocutaneous candidiasis was reported in families of French Canadian descent, originating from eastern Quebec (Germain et al., 1994). The disorder was of mild nature with adult onset, but complicated by fatal Candida meningitis. A total of 5 patients were reviewed. Germain et al. (1994) suggested that the disorder represents a variant of familial adult-onset chronic mucocutaneous candidiasis in which there is a striking predisposition to deep infection. Immunologic investigation showed a specific cellular deficit toward Candida albicans. One patient who died of meningitis was a 28-year-old woman who had suffered from recurrent episodes of mild oral thrush since age 16 years. She had no skin or nail involvement.

Boudghene-Stambouli and Merad-Boudia (1998) described a 29-year-old Algerian man, born of first-cousin parents, who had a 2-year history of progressive dermatophytic disease consisting of exuberant hyperkeratosis and cutaneous horns. Examination revealed erythematous flat plaques with distinct borders on the trunk, limbs, and neck, with verrucous midface lesions and other eczema-like lesions on the face, as well as papulonodular lesions around the left nipple. The lesions were intensely pruritic, and chronic scratching had caused lichenification. On the anterior plantar surface of each foot, there was a wide-based, dark-brown hard horn that made walking difficult. In addition, the patient had pachyonychia of all nails, some of which exhibited onychogryphosis. Histologic examination of affected skin showed acanthosis and papillomatosis of the epidermis, with marked hyperkeratosis. The stratum corneum was invaded by hyphae that penetrated into the sweat glands and hair follicles, and abscesses and small granulomas containing hyphae were seen in the superficial dermis. No other family members were affected. Boudghene-Stambouli and Merad-Boudia (1998) suggested that this phenotype with giant cutaneous horns represented a new variant of dermatophytic disease.

Glocker et al. (2009) studied a large consanguineous Iranian family segregating autosomal recessive chronic mucocutaneous candidiasis. Recurrent fungal infections were diagnosed clinically in 8 family members, 3 of whom died in early adolescence, 2 with proven and 1 with presumed invasive Candida infection of the brain. None of the 8 infected patients had unusual bacterial or viral infections, suggesting that host defenses against those pathogens was normal. In the 3 patients for whom laboratory studies were available, complete blood counts were within the normal range, as were total counts of CD3+, CD4+, and CD8+ T cells; memory, follicular helper, effector, and regulatory T cells; B cells; and natural killer cells. Basal levels of serum immunoglobulin were also normal. In 1 patient, a delayed-type hypersensitivity skin test was negative for tuberculin but positive for Candida. Compared to healthy family members and controls, affected family members had significantly lower proportions of Th17 cells, helper T cells producing interleukin-17 (603149) that are important for antifungal immunity.

Drewniak et al. (2013) studied a 13-year-old Asian girl who was adopted as an infant and at 7 years of age developed fever, headaches, behavioral changes, and seizures. She was diagnosed with Candida dubliniensis meningoencephalitis, but did not have any obvious underlying risk factors for fungal meningitis. MRI showed a deep infarction of the left striatum, meningeal enhancement, and mild ventricular dilation. After 6 months of antimycotic treatment, its discontinuation resulted in a clinical relapse, and cerebrospinal fluid (CSF) cultures revealed C. dubliniensis. Clinical signs and CSF eosinophilic pleocytosis resolved within several weeks of restarting combined antifungal therapy. Western blot analysis of patient neutrophils showed apparent absence of CARD9 protein, and this was confirmed with anti-CARD9 antibodies. Activated patient T-cell cultures showed clear induction of various cytokines but reduced levels of Th17-derived IL17 (see 603149), consistent with the findings of Glocker et al. (2009).

Lanternier et al. (2013) described 17 patients from 8 unrelated families of Moroccan, Tunisian, and Algerian ancestry, including the Algerian family originally described by Boudghene-Stambouli and Merad-Boudia (1998), who had deep dermatophytosis and no known immunodeficiency. In all patients, symptoms first appeared in childhood or early adulthood. Four patients had adenitis caused by dermatophyte infection, and 13 had documented cutaneous deep dermatophytosis. Skin lesions included extensive erythematosquamous lesions and nodular subcutaneous or ulcerative fistulized infiltrations. Fifteen patients had severe onychomycosis, and 2 patients had contiguous locoregional extension to the bone or digestive tract; manifestations of the disease in other extradermatologic locations included lymphadenopathy in 10 patients and probable brain involvement in 1. Four patients with clinically active deep dermatophytosis died at the ages of 28, 29, 37, and 39 years. None of the 17 patients had any detectable T-cell immunodeficiency known to confer a predisposition to severe dermatophyte infection. Skin histology showed multifocal-to-coalescing granulomatous dermatitis that extended throughout the dermis and was characterized by infiltrates of activated macrophages and epithelioid cells, associated with lymphocytes, plasma cells, neutrophils, and eosinophils. Pseudohyphae and irregularly branched hyaline septate hyphae could be seen within granulomas and sometimes even in the cytoplasm of multinucleated giant cells. Lymph node histology revealed granulomas containing hyphae and necrosis in 4 patients.

Wang et al. (2014) reported 4 unrelated patients with subcutaneous phaeohyphomycosis caused by P. verrucosa and Th17 cell deficiencies.

Wang et al. (2018) reported 3 patients, aged 18, 38 and 53 years, with phaeohyphomycosis caused by rare dermatiaceous fungi. Histopathologic analysis of skin from each patient demonstrated infectious granulomas with irregularly branched brown hyphae and lack of neutrophil infiltration.

Paccoud et al. (2022) reported a Moroccan patient who developed an ulcer on her ankle at 22 years of age when she was pregnant. A biopsy of the lesion showed spherical hyphae and she was treated with surgical excision and amphotericin B. She developed a hard-palate necrosis at age 25 during a subsequent pregnancy. The lesion did not heal despite treatment with amphotericin, and at age 28, she had lesions of the dosum nasi and hard palate with destruction of the nasal septum. The infection was shown to be due to Alternaria infectoria.


Pathogenesis

In peripheral blood mononuclear cells (PBMCs) from a 13-year-old Asian girl with chronic Candida dubliniensis meningoencephalitis and CARD9 deficiency, Drewniak et al. (2013) observed a virtual absence of Candida-induced monocytic IL6 (147620) and IL1B (147720) release. The response to bacteria and various TLR (see 603030) ligands was only partly affected or not at all, and cells transduced with CARD9 showed recovery of monocytic cytokines. Patient neutrophils demonstrated a normal capacity to generate reactive oxygen species and normal recognition and signaling for immediate responses. Neutrophil-killing capacity of CARD9-deficient cells was significantly impaired with unopsonized C. albicans conidia, but was normal with serum-opsonized conidia, and with opsonized S. aureus or E. coli. Ultrastructural analysis showed abnormal bulging phagolysosome formation upon uptake of C. albicans in patient neutrophils compared to controls. Drewniak et al. (2013) concluded that CARD9 deficiency results in a selective defect in host defense against invasive fungal infection, due to impaired phagocyte killing.


Mapping

Glocker et al. (2009) performed homozygosity mapping in a large consanguineous Iranian family with chronic mucocutaneous candidiasis and identified a region of perfect segregation on chromosome 9; genotyping 4 microsatellite markers yielded a peak multipoint lod score of 3.6 at an interval defined by the markers D9S2157 and D9S1838. Forty-one genes were located in a perfectly segregating 1.3-Mb subinterval suggested by SNP data.


Inheritance

The transmission pattern of IMD103 in the family reported by Glocker et al. (2009) was consistent with autosomal recessive inheritance.


Molecular Genetics

In a large consanguineous Iranian family segregating autosomal recessive chronic mucocutaneous candidiasis mapping to chromosome 9, Glocker et al. (2009) identified homozygosity for a nonsense mutation (Q295X; 607212.0001) in the CARD9 gene in all 4 affected individuals. Eighteen other unaffected family members were either heterozygous or did not carry the Q295X mutation, and the mutation was not found in 50 unrelated Iranian controls or in 180 unrelated Caucasian controls. Functional studies showed that Q295X is a loss-of-function mutation that impairs innate signaling from the antifungal pattern-recognition receptor dectin-1 (CLEC7A; 606264).

In a 13-year-old Asian girl with chronic Candida dubliniensis meningoencephalitis, in whom CARD9 appeared to be absent from neutrophils, Drewniak et al. (2013) identified compound heterozygosity for 2 missense mutations in the CARD9 gene, G72S (607212.0002) and R373P (607212.0003).

In affected individuals from 8 families of Algerian, Tunisian, and Moroccan ancestry with deep dermatophytosis, including the Algerian family previously studied by Boudghene-Stambouli and Merad-Boudia (1998), Lanternier et al. (2013) analyzed the candidate gene CARD9 and identified homozygosity for a nonsense mutation (Q289X; 607212.0004) in 7 of the families; patients from the eighth family were homozygous for a CARD9 missense mutation (R101C; 607212.0005). The mutations segregated fully with disease in each family and were not found in ethnically matched controls, in more than 1,000 exomes, or in the 1000 Genomes Project database.

Wang et al. (2014) identified biallelic mutations in the CARD9 gene in 4 unrelated Chinese patients with subcutaneous phaeohyphomycosis, including 1 (patient 1) with compound heterozygous mutations (607212.0006-607212.0007) and 3 (patients 2-4) with a homozygous mutation (607212.0008). Haplotype analysis in the homozygous patients demonstrated that the mutation likely arose from a shared founder. In patients 1, 2, and 3, expression of mature CARD9 protein was absent in peripheral mononuclear blood cells, and Th17 cells and the related cytokines IL17 and IL22 (605330) were decreased in blood/serum. Induced macrophages and immature dendritic cells from patients 1 and 3 secreted lower cytokines when exposed to P. verrucosa spores compared to controls. Wang et al. (2014) concluded that these results confirm the pivotal role of CARD9 in antifungal defense.

Wang et al. (2018) identified biallelic mutations in the CARD9 gene in 3 unrelated Chinese patients with IMD103, including compound heterozygous mutations (607212.0006, 607212.0008, 607212.0009) in 2 (patients 1 and 3) and a homozygous mutation (607212.0008) in 1 (patient 2). CARD9 protein expression was absent in polymorphonuclear cells from each patient. Studies in cells from patient 1 showed impaired proinflammatory chemokine (TNF-alpha, 191160; IL6, 147620; IL1B, 147720) and cytokine (CXCL1, 155730; CXCL2, 139110; CXCL8, 146930) production, deficient NF-kappa-B (see 164011) activation, and impaired Th22 and Th17 cells following fungal stimulation.


REFERENCES

  1. Boudghene-Stambouli, O., Merad-Boudia, A. Maladie dermatophytique: hyperkeratose exuberante avec cornes cutanees. Ann. Derm. Venereol. 125: 705-707, 1998. [PubMed: 9835960]

  2. Drewniak, A., Gazendam, R. P., Tool, A. T. J., van Houdt, M., Jansen, M. H., van Hamme, J. L., van Leeuwen, E. M. M., Roos, D., Scalais, E., de Beaufort, C., Janssen, H., van den Berg, T. K., Kuijpers, T. W. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121: 2385-2392, 2013. [PubMed: 23335372] [Full Text: https://doi.org/10.1182/blood-2012-08-450551]

  3. Germain, M., Gourdeau, M., Hebert, J. Familial chronic mucocutaneous candidiasis complicated by deep Candida infection. Am. J. Med. Sci. 307: 282-283, 1994. [PubMed: 8160723] [Full Text: https://doi.org/10.1097/00000441-199404000-00008]

  4. Glocker, E.-O., Hennigs, A., Nabavi, M., Schaffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., Jamal, S., Manguiat, A., Rezaei, N., Amirzargar, A. A., Plebani, A., Hannesschlager, N., Gross, O., Ruland, J., Grimbacher, B. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. New Eng. J. Med. 361: 1727-1735, 2009. [PubMed: 19864672] [Full Text: https://doi.org/10.1056/NEJMoa0810719]

  5. Higgs, J. M., Wells, R. S. Chronic muco-cutaneous candidiasis: associated abnormalities of iron metabolism. Brit. J. Derm. 86 (suppl. 8): 88-102, 1972.

  6. Lanternier, F., Pathan, S., Vincent, Q. B., Liu, L., Cypowyj, S., Prando, C., Migaud, M., Taibi, L., Ammar-Khodja, A., Boudghene Stambouli, O., Guellil, B., Jacobs, F., and 21 others. Deep dermatophytosis and inherited CARD9 deficiency. New Eng. J. Med. 369: 1704-1714, 2013. [PubMed: 24131138] [Full Text: https://doi.org/10.1056/NEJMoa1208487]

  7. Paccoud, O., Vignier, N., Boui, M., Migaud, M., Vironneau, P., Kania, R., Mechai, F., Brun, S., Alanio, A., Tauziede-Espariat, A., Adle-Biassette, H., Ouedraogo, E., Bustamante, J., Bouchaud, O., Casanova, J. L., Puel, A., Lanternier, F. Invasive rhinosinusitis caused by Alternaria infectoria in a patient with autosomal recessive CARD9 deficiency and a review of the literature. J Fungi (Basel) 8: 446, 2022. [PubMed: 35628702] [Full Text: https://doi.org/10.3390/jof8050446]

  8. Wang, X., Wang, W., Lin, Z., Wang, X., Li, T., Yu, J., Liu, W., Tong, Z., Xu, Y., Zhang, J., Guan, L., Dai, L., Yang, Y., Han, W., Li, R. CARD9 mutations linked to subcutaneous phaeohyphomycosis and TH17 cell deficiencies. (Letter) J. Allergy Clin. Immun. 133: 905-8.e3, 2014. [PubMed: 24231284] [Full Text: https://doi.org/10.1016/j.jaci.2013.09.033]

  9. Wang, X., Zhang, R., Wu, W., Song, Y., Wan, Z., Han, W., Li, R. Impaired specific antifungal immunity in CARD9-deficient patients with phaeohyphomycosis. J. Invest. Derm. 138: 607-617, 2018. [PubMed: 29080677] [Full Text: https://doi.org/10.1016/j.jid.2017.10.009]

  10. Wells, R. S., Higgs, J. M., McDonald, A., Valdimarsson, H., Holt, P. J. L. Familial chronic muco-cutaneous candidiasis. J. Med. Genet. 9: 302-310, 1972. [PubMed: 4562433] [Full Text: https://doi.org/10.1136/jmg.9.3.302]


Contributors:
Hilary J. Vernon - updated : 10/05/2022
Hilary J. Vernon - updated : 07/27/2022
Marla J. F. O'Neill - updated : 8/14/2015
Marla J. F. O'Neill - updated : 11/20/2013
Marla J. F. O'Neill - updated : 10/30/2009

Creation Date:
Victor A. McKusick : 6/3/1986

Edit History:
carol : 04/02/2024
carol : 10/05/2022
carol : 07/28/2022
carol : 07/27/2022
carol : 06/17/2022
carol : 06/16/2022
carol : 08/17/2015
mcolton : 8/14/2015
carol : 8/26/2014
carol : 11/20/2013
mcolton : 11/15/2013
carol : 11/2/2009
terry : 10/30/2009
alopez : 3/18/2004
carol : 10/26/2001
carol : 5/24/1994
mimadm : 2/19/1994
supermim : 3/16/1992
supermim : 3/20/1990
ddp : 10/26/1989
marie : 3/25/1988